Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
35.01
-0.26 (-0.74%)
At close: Dec 5, 2025, 4:00 PM EST
35.03
+0.02 (0.06%)
After-hours: Dec 5, 2025, 5:55 PM EST
Assembly Biosciences Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Assembly Biosciences stock ranges from a low of $38 to a high of $50. The average analyst price target of $43.4 forecasts a 23.96% increase in the stock price over the next year.
Price Target: $43.40 (+23.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Assembly Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 1 | 1 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $29 → $40 | Buy | Maintains | $29 → $40 | +14.25% | Nov 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +42.82% | Oct 14, 2025 |
| JMP Securities | JMP Securities | Buy Initiates $38 | Buy | Initiates | $38 | +8.54% | Sep 24, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $31 → $39 | Strong Buy | Maintains | $31 → $39 | +11.40% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +42.82% | Aug 18, 2025 |
Financial Forecast
Revenue This Year
40.50M
from 28.52M
Increased by 42.01%
Revenue Next Year
29.70M
from 40.50M
Decreased by -26.66%
EPS This Year
-3.63
from -6.69
EPS Next Year
-3.75
from -3.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 42.4M | 43.2M | ||||
| Avg | 40.5M | 29.7M | ||||
| Low | 37.5M | 13.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 48.8% | 6.7% | ||||
| Avg | 42.0% | -26.7% | ||||
| Low | 31.6% | -66.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.47 | -2.43 | ||||
| Avg | -3.63 | -3.75 | ||||
| Low | -3.79 | -6.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.